Genetics of Mortality in Critical Care (GenOMICC)
Principal Investigator(s):
David Maslove (Canadian study lead), Kenneth Baillie (PI)
Status:
Enrolment Complete
This study is part of GenOMICC International (UK-led initiative).
View publication Genetic mechanisms of critical illness in COVID-19
Our results identify robust genetic signals relating to key host antiviral defence mechanisms and mediators of inflammatory organ damage in COVID-19. Both mechanisms may be amenable to targeted treatment with existing drugs. However, large-scale randomized clinical trials will be essential before any change to clinical practice.
For more information visit the GenOMICC site
Coordinators:
Participating Centres:
Kingston Health Sciences Centre, Sunnybrook Hospital, Sinai Health, Niagara Health
Co-investigators:
Kenneth Baillie, Rob Fowler, Jennifer Tsang, Laveena Munshi